Edition:
United Kingdom

Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

15.45EUR
13 Aug 2018
Change (% chg)

€-0.44 (-2.77%)
Prev Close
€15.89
Open
€15.75
Day's High
€15.82
Day's Low
€15.23
Volume
506,985
Avg. Vol
391,738
52-wk High
€15.94
52-wk Low
€7.28

Chart for

About

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating... (more)

Overall

Beta: 0.38
Market Cap(Mil.): €1,457.98
Shares Outstanding(Mil.): 172.95
Dividend: 0.19
Yield (%): 2.25

Financials

  ALM.MC Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.45 -- --
ROI: -3.49 15.07 14.61
ROE: -5.42 16.60 16.33

Spain's Almirall bets on dermatology with $650 million U.S. deal

Spanish pharmaceutical company Almirall said on Friday it had agreed to buy five dermatology brands from U.S. company Allergan for up to $650 million in cash.

03 Aug 2018

UPDATE 1-Spain's Almirall bets on dermatology with $650 mln U.S. deal

Aug 3 Spanish pharmaceutical company Almirall said on Friday it had agreed to buy five dermatology brands from U.S. company Allergan for up to $650 million in cash.

03 Aug 2018

Spain's Almirall to buy U.S. dermatology portfolio from Allergan

Aug 3 Spanish pharmaceutical company Almirall SA said on Friday it has agreed to buy a portfolio of five brands from U.S. firm Allergan for up to $650 million in cash.

03 Aug 2018

Spanish stocks - Factors to watch on Friday

The following Spanish stocks may be affected by newspaper reports and other factors on Friday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

03 Aug 2018

BRIEF-Almirall Sees 20 Pct EBITDA Growth In 2018

* FY EBITDA 142.2 MILLION EUROS VERSUS 227.6 MILLION EUROS YEAR AGO

23 Feb 2018

BRIEF-Almirall FY Net Result Turns To Loss Of 304 Million Euros

* FY NET LOSS 304.0 MILLION EUROS VERSUS PROFIT OF 75.5 MILLION EUROS YEAR AGO

23 Feb 2018

Earnings vs. Estimates